No DIR Reform in CMS’ 2020 Final Drug Pricing Rule

Despite over 4,000 comments from pharmacists and organizations like Currus, NCPA, the National Association of Chain Drug Stores (NACDS), and others across the country encouraging change, CMS elected not to address DIR reform in their final 2020 drug pricing rule released on Thursday. CMS said in a statement that they “will continue to carefully review…

Read More

Everything Old is New Again?

Image courtesy of

National Community Pharmacists Association (NCPA) CEO Douglas Hoey recently wrote an op-ed piece for Morning Consult on behalf of independent pharmacies. In the piece he gives a thoughtful reminder about some of the personalized services that independent pharmacies have been providing patients for years – despite mergers and mail order making headlines regarding their “new” services.…

Read More